About this item

Issue date:
2 April 2007
Corporate Author:
National Screening Unit
Antenatal and newborn screening, Maternity, Screening


Antenatal Down Syndrome Screening in New Zealand 2007 was the result of work carried out by the Antenatal Down Syndrome Screening Advisory Group. The report recommended important changes to improve the quality and safety of antenatal screening for Down syndrome in New Zealand.

The Advisory Group recommended that the practice of screening using only maternal age and/or nuchal translucency (NT), without biochemical markers was unsafe, inequitable, and should not continue. The Advisory Group made a number of recommendations for ways to improve the safety and quality of antenatal Down syndrome screening. These recommendations took into consideration the social, ethical, medical and technical implications.